| Literature DB >> 28813487 |
Nobuyuki Okuma1, Makiko Saita1, Noriyuki Hoshi1, Tomoyoshi Soga2, Masaru Tomita2, Masahiro Sugimoto2,3,4, Katsuhiko Kimoto1.
Abstract
BACKGROUND: This study characterized the changes in quality and quantity of saliva, and changes in the salivary metabolomic profile, to understand the effects of masticatory stimulation.Entities:
Mesh:
Year: 2017 PMID: 28813487 PMCID: PMC5557591 DOI: 10.1371/journal.pone.0183109
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subject characteristics.
| Characteristics | n | Ave | Stdev | ||
|---|---|---|---|---|---|
| Age | |||||
| Total | 55 | 28.15 | 3.82 | - | |
| Sex | Male | 36 | 28.22 | 3.64 | 0.61 |
| Age | Female | 19 | 28.00 | 4.23 | |
| Smoking | Yes | 9 | 28.89 | 4.11 | 0.51 |
| No | 46 | 28.00 | 3.79 | ||
| Unstimulated salivary volume (mL) | |||||
| Total | 55 | 7.14 | 2.62 | - | |
| Sex | Male | 36 | 7.29 | 3.05 | 0.57 |
| Female | 19 | 6.87 | 1.57 | ||
| Smoking | Yes | 9 | 6.69 | 0.83 | 0.36 |
| No | 46 | 7.23 | 2.84 | ||
| Stimulated salivary volume (mL) | |||||
| Total | 55 | 14.33 | 3.55 | - | |
| Sex | Male | 36 | 14.53 | 3.73 | 0.72 |
| Female | 19 | 13.94 | 3.26 | ||
| Smoking | Yes | 9 | 13.88 | 2.51 | 0.50 |
| No | 46 | 14.41 | 3.39 | ||
Note: P-values were calculated using Mann–Whitney test
Fig 1Heat map of salivary metabolite concentrations.
Red, white, and blue indicate relatively higher, average and lower concentrations, respectively. Those identified by the black box (bottom of the figure) were from the stimulated saliva samples, and the others were from the unstimulated samples. Clustering was conducted using Pearson correlation. Metabolite names are colored depending on the corrected P-values between the 2 groups.
Fig 2Score plots of principal component analysis (PCA) of salivary metabolomic profiles, where A) unstimulated (open) and stimulated (filled); and B) line-dot plots of PC1 and PC2. Contribution ratios of PC1 and PC2 are described at the X and Y axis. P-values were calculated using the Wilcoxon matched pairs test.
Fig 3Loading plots of principal component analysis (PCA).
Fig 4Correlation between metabolite concentration of salivary volume for unstimulated (A) and stimulated (B) saliva. The relationship between metabolite concentration and salivary volume for the metabolites was significantly correlated (P-value<0.05, Spearman ranked correlation), and is visualized in small panels. Regression lines show the overall trends.
Ranking of pathways and related correlation between unstimulated and stimulated saliva samples.
| Rank | Pathway | Correlated | |
|---|---|---|---|
| 1 | Urea cycle | 1.1E-09 | 1.5E-07 |
| 2 | Glycine, serine, cysteine and threonine metabolism | 8.7E-08 | 3.5E-06 |
| 3 | Aminoacyl-tRNA biosynthesis in mitochondrion | 9.5E-08 | 3.5E-06 |
| 4 | Aminoacyl-tRNA biosynthesis in cytoplasm | 3.3E-07 | 8.3E-06 |
| 5 | Aspartate and asparagine metabolism | 1.2E-06 | 2.3E-05 |
| 6 | (L)-Arginine metabolism | 1.4E-06 | 2.3E-05 |
| 7 | Nociception_Pro-nociceptive action of Nociceptin in spinal cord | 1.5E-06 | 2.3E-05 |
| 8 | Tricarbonic acid cycle | 4.0E-06 | 5.6E-05 |
| 9 | Neurophysiological process_Circadian rhythm | 7.1E-05 | 8.3E-04 |
| 10 | Histidine-glutamate-glutamine metabolism | 8.5E-05 | 9.1E-04 |
| 11 | L-Alanine, L-cysteine, and L-methionine metabolism | 1.4E-04 | 1.4E-03 |
| 12 | Glycolysis and gluconeogenesis p.3 | 1.9E-04 | 1.6E-03 |
| 13 | Neurophysiological process_nNOS signaling in neuronal synapses | 3.4E-04 | 2.5E-03 |
| 14 | Regulation of lipid metabolism_PPAR regulation of lipid metabolism | 1.0E-03 | 7.3E-03 |
| 15 | Nicotine signaling in cholinergic neurons | 1.7E-03 | 1.2E-02 |
| 22 | Proline metabolism | 1.8E-03 | 1.2E-02 |
| 23 | Mitochondrial dysfunction in neurodegenerative diseases | 2.8E-03 | 1.7E-02 |
| 24 | Glycine links | 4.8E-03 | 2.7E-02 |
| 25 | Glutamate links | 4.8E-03 | 2.7E-02 |
| 26 | N-Acylethanolamines, HSRL5-transacylation pathway | 7.3E-03 | 3.9E-02 |
| 27 | Lysine metabolism | 7.5E-03 | 3.9E-02 |
| 29 | Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism | 8.8E-03 | 4.2E-02 |
| 31 | Nicotine signaling in glutamatergic neurons | 1.1E-02 | 4.9E-02 |
| 32 | Cannabinoid receptor signaling in nicotine addiction | 1.1E-02 | 4.9E-02 |
| 33 | Beta-alanine metabolism | 1.1E-02 | 4.9E-02 |
| 34 | Nitrogen metabolism | 1.2E-02 | 5.0E-02 |
| 36 | IMP biosynthesis | 1.6E-02 | 6.1E-02 |
| 38 | Pentose phosphate pathway | 1.8E-02 | 6.1E-02 |
| 39 | Leucine, isoleucine and valine metabolism | 1.8E-02 | 6.1E-02 |
| 40 | Methionine-cysteine-glutamate metabolism | 1.8E-02 | 6.1E-02 |
| 41 | Neurophysiological process_PGE2-induced pain processing | 1.8E-02 | 6.1E-02 |
| 42 | Immune response_IL-13 signaling via JAK-STAT | 1.9E-02 | 6.2E-02 |
| 43 | Nicotine signaling in dopaminergic neurons, Pt. 1—cell body | 2.2E-02 | 7.1E-02 |
| 44 | Pyruvate metabolism | 2.3E-02 | 7.1E-02 |
| 45 | Neurophysiological process_Long-term depression in cerebellum | 2.3E-02 | 7.1E-02 |
| 46 | Impaired NO signaling in CF airways | 2.4E-02 | 7.1E-02 |
| 47 | Immune response_IL-13 signaling via PI3K-ERK pathway | 2.4E-02 | 7.1E-02 |
| 48 | Gamma-aminobutyrate (GABA) biosynthesis and metabolism | 2.7E-02 | 7.7E-02 |
| 49 | Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery | 3.2E-02 | 9.2E-02 |
| 50 | Glutathione metabolism | 3.8E-02 | 1.0E-01 |
Fig 5The metabolic pathways that ranked first in the pathway analysis, and using only metabolites, showed significant differences (P<0.05, Wilcoxon matched pairs test, corrected by false discovery rate) between unstimulated and stimulated saliva samples.
The red bar indicates the average concentrations of unstimulated (left) and stimulated (right) saliva. To clearly visualize the data, these data were divided by the average of unstimulated saliva.